Shanghai Aladdin Biochemical TechnologyLtd Future Growth

Future criteria checks 5/6

Shanghai Aladdin Biochemical TechnologyLtd is forecast to grow earnings and revenue by 48.6% and 23.6% per annum respectively. EPS is expected to grow by 55.9% per annum. Return on equity is forecast to be 13.5% in 3 years.

Key information

48.6%

Earnings growth rate

55.9%

EPS growth rate

Chemicals earnings growth	32.6%
Revenue growth rate	23.6%
Future return on equity	13.5%
Analyst coverage	Low
Last updated	19 Apr 2024

Recent future growth updates

No updates

Recent updates

Is Now An Opportune Moment To Examine Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHSE:688179)?

Apr 23

Earnings and Revenue Growth Forecasts

SHSE:688179 - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	800	N/A	N/A	136	1
12/31/2025	661	228	N/A	54	1
12/31/2024	512	177	N/A	150	1
3/31/2024	415	86	46	92	N/A
12/31/2023	403	86	10	56	N/A
9/30/2023	395	81	-42	5	N/A
6/30/2023	386	73	-122	-50	N/A
3/31/2023	373	79	-118	-51	N/A
12/31/2022	378	93	-105	-43	N/A
9/30/2022	356	95	-162	-45	N/A
6/30/2022	335	98	-90	-12	N/A
3/31/2022	317	100	-99	3	N/A
12/31/2021	288	89	-98	15	N/A
9/30/2021	272	86	-4	49	N/A
6/30/2021	273	92	22	75	N/A
3/31/2021	261	86	62	88	N/A
12/31/2020	234	74	72	81	N/A
9/30/2020	223	68	62	70	N/A
6/30/2020	206	59	56	63	N/A
3/31/2020	203	60	47	54	N/A
12/31/2019	210	64	50	56	N/A
9/30/2019	200	64	52	63	N/A
6/30/2019	188	60	34	46	N/A
3/31/2019	176	61	21	35	N/A
1/1/2019	166	53	28	39	N/A
9/30/2018	158	46	2	5	N/A
6/30/2018	148	44	19	24	N/A
3/31/2018	137	34	20	29	N/A
1/1/2018	126	32	N/A	33	N/A
9/30/2017	112	26	N/A	41	N/A
6/30/2017	111	24	N/A	39	N/A
3/31/2017	105	23	N/A	31	N/A
1/1/2017	106	21	N/A	31	N/A
9/30/2016	105	25	N/A	27	N/A
6/30/2016	104	28	N/A	22	N/A
3/31/2016	102	29	N/A	16	N/A
1/1/2016	101	30	N/A	10	N/A
9/30/2015	94	27	N/A	12	N/A
6/30/2015	87	25	N/A	14	N/A
3/31/2015	84	25	N/A	23	N/A
12/31/2014	80	25	N/A	31	N/A
9/30/2014	77	23	N/A	28	N/A
6/30/2014	73	21	N/A	24	N/A
3/31/2014	69	20	N/A	17	N/A
1/1/2014	65	19	N/A	10	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688179's forecast earnings growth (48.6% per year) is above the savings rate (2.9%).

Earnings vs Market: 688179's earnings (48.6% per year) are forecast to grow faster than the CN market (24.4% per year).

High Growth Earnings: 688179's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688179's revenue (23.6% per year) is forecast to grow faster than the CN market (14.6% per year).

High Growth Revenue: 688179's revenue (23.6% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 688179's Return on Equity is forecast to be low in 3 years time (13.5%).

Shanghai Aladdin Biochemical TechnologyLtd Future Growth

Future criteria checks 5/6

Key information

Recent future growth updates

Recent updates

First quarter 2024 earnings released: EPS: CN¥0.09 (vs CN¥0.086 in 1Q 2023)

Is Now An Opportune Moment To Examine Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHSE:688179)?

Shanghai Aladdin Biochemical Technology Co.,Ltd., Annual General Meeting, Apr 22, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorates as stock falls 15%

Investor sentiment improves as stock rises 16%

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.074 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.074 (vs CN¥0.099 in 2Q 2022)

Investor sentiment deteriorates as stock falls 29%

Shanghai Aladdin Biochemical Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 29, 2023

First quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.22 in 1Q 2022)

Full year 2022 earnings released: EPS: CN¥0.67 (vs CN¥0.64 in FY 2021)

Third quarter 2022 earnings released: EPS: CN¥0.10 (vs CN¥0.13 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.15 in 2Q 2021)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: CN¥0.31 (vs CN¥0.20 in 1Q 2021)

Full year 2021 earnings released: EPS: CN¥0.89 (vs CN¥0.93 in FY 2020)

Investor sentiment deteriorated over the past week

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.32 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.21 in 2Q 2020)

Full year 2020 earnings released: EPS CN¥0.93 (vs CN¥0.84 in FY 2019)

New 90-day high: CN¥106

Market bids up stock over the past week

Market bids up stock over the past week

Market bids up stock over the past week

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies